You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ESLA Exercise Disclosure
Xu Jiandong · SEC Form 4 · Filed Aug 25, 2026
Exercise
Reported value range
Not reported
Xu Jiandong Chief Financial Officer
ESLA
Transaction date
Aug 18, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 7 days later
ESLA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Incentive Share Option on Common Stock
- Quantity / price
- 100,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001213900-26-093698
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$81.5K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Estrella Immunopharma, Inc. ESLA Current | Exercise | Aug 18, 2026 | Not reported |
| Estrella Immunopharma, Inc. ESLA | Exercise | Aug 18, 2026 | $81.5K |